Table 1.
Information and comorbidities between pulmonary tuberculosis cases and controls.
| Variable | Controls N = 8236 | Cases N = 8236 | P-value* | ||
|---|---|---|---|---|---|
| n | (%) | n | (%) | ||
| Sex | 0.95 | ||||
| Female | 2,516 | (30.6) | 2,520 | (30.6) | |
| Male | 5,720 | (69.4) | 5,716 | (69.4) | |
| Age group (years) | 0.96 | ||||
| 20–39 | 1,409 | (17.1) | 1,408 | (17.1) | |
| 40–64 | 3,000 | (36.4) | 3,016 | (36.6) | |
| 65–84 | 3,827 | (46.5) | 3,812 | (46.3) | |
| Age (years), mean (standard deviation)† | 59.3 | (17.2) | 59.3 | (17.3) | 0.91 |
| Duration of exposure to statins (months), mean (standard deviation)† | 23.7 | (26.6) | 19.2 | (23.8) | 0.001 |
| Ever use of statins | 841 | (10.2) | 590 | (7.16) | <0.001 |
| Ever use of non-statin lipid-lowering drugs | 940 | (11.4) | 783 | (9.51) | <0.001 |
| COMORBIDITIES | |||||
| Alcohol-related disease | 637 | (7.73) | 671 | (8.15) | 0.33 |
| Chronic kidney disease | 8,236 | (4.83) | 415 | (5.04) | 0.54 |
| Chronic liver disease | 1,381 | (16.8) | 1,391 | (16.9) | 0.84 |
| Chronic obstructive pulmonary disease | 2,837 | (34.5) | 2,838 | (34.5) | 0.99 |
| Diabetes mellitus | 1,202 | (14.6) | 1,294 | (15.7) | 0.05 |
| Human immunodeficiency virus infection | 28 | (0.34) | 28 | (0.34) | 0.99 |
| Gastrectomy | 35 | (0.42) | 35 | (0.42) | 0.99 |
| Pneumoconiosis | 250 | (3.04) | 245 | (2.97) | 0.82 |
Data are presented as the number of subjects in each group with percentages given in parentheses, or the mean with standard deviation given in parentheses.
*
Chi-square test, and
†
T-test comparing subjects with and without pulmonary tuberculosis.